Jefferies resumed coverage on TG Therapeutics with a new price target

6/26/23 9:08:22 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Jefferies resumed coverage of TG Therapeutics with a rating of Buy and set a new price target of $40.00 from $55.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TGTX

Date	Price Target	Rating	Analyst
10/29/2024	$50.00	Buy	TD Cowen
8/2/2023	$16.00 → $12.00	Sell → Neutral	Goldman
6/26/2023	$55.00 → $40.00	Buy	Jefferies
5/20/2022	$5.00	Underperform	BofA Securities
2/23/2022	$49.00 → $35.00	Buy	B. Riley Securities
1/28/2022	$70.00 → $68.00	Buy	HC Wainwright & Co.
1/24/2022	$75.00 → $70.00	Buy	HC Wainwright & Co.
12/1/2021	$55.00 → $36.00	Outperform	Evercore ISI Group